Beta Bionics (BBNX) Payables (2023 - 2026)

Beta Bionics' Payables history runs 4 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Payables fell 32.89% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (down 32.89% YoY), while the FY2025 annual figure was $5.0 million, up 75.25% from the prior year.
• Payables came in at $2.3 million for Q1 2026 at Beta Bionics, down from $5.0 million in the prior quarter.
• In the past five years, Payables ranged from a high of $5.0 million in Q4 2025 to a low of $1.2 million in Q4 2023.
• A 4-year average of $3.2 million and a median of $3.4 million in 2025 frame the typical range for Payables.
• Across the five-year window, Payables surged 144.6% in 2024 and tumbled 32.89% in 2026, its largest moves.
• Beta Bionics' Payables stood at $1.2 million in 2023, then surged by 144.6% to $2.9 million in 2024, then soared by 75.25% to $5.0 million in 2025, then sank by 53.62% to $2.3 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $2.3 million, $5.0 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison